Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.19.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net loss $ (9,408) $ (9,091)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 147 27
Stock-based compensation 1,155 825
License rights expense settled in stock 490 0
Gain from change in fair value of warrant liability (3,059) (1,614)
Operating lease, net (10)  
Loss on foreign currency transactions 0 23
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (2,337) (172)
Accounts payable 1,942 (25)
Accrued expenses and other current liabilities (1,441) 923
Other long-term liabilities 0 11
Net cash used in operating activities (12,521) (9,093)
Cash flows from investing activities:    
Purchase of fixed assets (42) (303)
Net cash used in investing activities (42) (303)
Cash flows from financing activities:    
Proceeds from exercise of stock options 5 0
Proceeds from exercise of warrants 1,557 15
Proceeds from sale of common stock, net of issuance costs 19,292 10,269
Net cash provided by financing activities 20,854 10,284
Effect of exchange rate changes on cash and cash equivalents (16) (2)
Net change in cash and cash equivalents 8,275 886
Cash and cash equivalents, at beginning of period 7,134 7,714
Cash and cash equivalents, at end of period 15,409 8,600
Supplemental disclosures of cash flow information:    
Cash paid for interest 1 3
Cash paid for taxes 15 20
Property and equipment in accrued liabilities 21 136
Leasehold improvements paid by landlord 0 82
Research and development expense settled in stock $ 490 $ 0